Stephen Beard Sells 2,762 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,762 shares of Adtalem Global Education stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $130.14, for a total value of $359,446.68. Following the sale, the chief executive officer directly owned 426,562 shares of the company’s stock, valued at $55,512,778.68. This represents a 0.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 2.8%

Shares of CVSA traded down $3.66 during midday trading on Friday, reaching $128.23. 295,964 shares of the stock were exchanged, compared to its average volume of 254,545. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $4.36 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.09 and a beta of 0.62. The firm has a 50 day moving average of $120.70.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company had revenue of $487.03 million during the quarter. During the same period in the prior year, the business posted $1.92 EPS. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently commented on CVSA. Truist Financial boosted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Wall Street Zen downgraded Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.